Weiss Multi Strategy Advisers LLC Haemonetics Corp Transaction History

Weiss Multi Strategy Advisers LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $427,932 - $491,759	-5,310 Reduced 16.59%	26,690 $2.28 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $546,960 - $619,371	-6,625 Reduced 17.15%	32,000 $2.87 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $214,468 - $237,310	-2,653 Reduced 6.43%	38,625 $3.29 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $965,974 - $1.2 Million	13,278 Added 47.42%	41,278 $3.42 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $195,702 - $228,271	2,650 Added 10.45%	28,000 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $560,205 - $696,141	8,850 Added 53.64%	25,350 $1.88 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $73,707 - $98,855	1,496 Added 9.97%	16,500 $1.08 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $127,108 - $183,590	-2,904 Reduced 16.22%	15,004 $949,000
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $32,356 - $48,707	653 Added 3.78%	17,908 $950,000
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $129,888 - $159,180	2,255 Added 15.03%	17,255 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $777,150 - $1.78 Million	15,000 New	15,000 $1 Million
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $555,050 - $697,400	-5,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $458,305 - $619,421	-5,164 Reduced 50.81%	5,000 $594,000
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $8,624 - $10,668	114 Added 1.13%	10,164 $887,000
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $853,847 - $1.2 Million	10,050 New	10,050 $900,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.